NEW YORK (GenomeWeb News) – GNS Healthcare will work with researchers at Dana-Farber Cancer Institute and Mount Sinai School of Medicine to create computer models of multiple myeloma for use in developing new therapies, the data analytics firm said today.

GNS said it will use its REFS (reverse engineering and forward simulation) platform to create network models from next-generation genome sequencing, proteomic, and clinical data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.